Commercially Available Flavonols Are Better SARS-CoV-2 Inhibitors than Isoflavone and Flavones

Despite the fast development of vaccines, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is still circulating and generating variants of concern (VoC) that escape the humoral immune response. In this context, the search for anti-SARS-CoV-2 compounds is still essential. A class of natur...

Descripción completa

Detalles Bibliográficos
Autores principales: Chaves, Otávio Augusto, Fintelman-Rodrigues, Natalia, Wang, Xuanting, Sacramento, Carolina Q., Temerozo, Jairo R., Ferreira, André C., Mattos, Mayara, Pereira-Dutra, Filipe, Bozza, Patrícia T., Castro-Faria-Neto, Hugo Caire, Russo, James J., Ju, Jingyue, Souza, Thiago Moreno L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9324382/
https://www.ncbi.nlm.nih.gov/pubmed/35891437
http://dx.doi.org/10.3390/v14071458

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9324382/
https://www.ncbi.nlm.nih.gov/pubmed/35891437
http://dx.doi.org/10.3390/v14071458

Ejemplares similares